Cписок использованной литературы.

1. Costa B. et al. Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABA A receptor activity //Psychoneuroendocrinology. – 2011. – Т. 36. – №. 4. – С. 463-472.

2. Tiihonen J. et al. Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis //Molecular psychiatry. – 1996. – Т. 2. – №. 6. – С. 463-471.

3. Davidson J. R. T. et al. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder //Journal of Clinical Psychiatry. – 1999.

4. Papadopoulos V. et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function //Trends in pharmacological sciences. – 2006. – Т. 27. – №. 8. – С. 402-409.

5. Rupprecht R. et al. Translocator protein (18 kDa)(TSPO) as a therapeutic target for neurological and psychiatric disorders //Nature reviews Drug discovery. – 2010. – Т. 9. – №. 12. – С. 971-988.

6. Zorumski C. F. et al. Neurosteroids, stress and depression: potential therapeutic opportunities //Neuroscience & Biobehavioral Reviews. – 2013. – Т. 37. – №. 1. – С. 109-122.

7. Vanover K. E. et al. Characterization of the anxiolytic properties of a novel neuroactive steroid, Co 2-6749 (GMA-839; WAY-141839; 3α, 21-dihydroxy-3β-trifluoromethyl-19-nor-5β-pregnan-20-one), a selective modulator of γ-aminobutyric acidA receptors //Journal of Pharmacology and Experimental Therapeutics. – 2000. – Т. 295. – №. 1. – С. 337-345.

8. Rupprecht R. et al. Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects //Science. – 2009. – Т. 325. – №. 5939. – С. 490-493.

9. Li H., Papadopoulos V. Peripheral-Type Benzodiazepine Receptor Function in Cholesterol Transport. Identification of a Putative Cholesterol Recognition/Interaction Amino Acid Sequence and Consensus Pattern 1 //Endocrinology. – 1998. – Т. 139. – №. 12. – С. 4991-4997.

10. Verma A., Nye J. S., Snyder S. H. Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor //Proceedings of the National Academy of Sciences. – 1987. – Т. 84. – №. 8. – С. 2256-2260.

11. Ferzaz B. et al. SSR180575 (7-chloro-N, N, 5-trimethyl-4-oxo-3-phenyl-3, 5-dihydro-4H-pyridazino [4, 5-b] indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair //Journal of Pharmacology and Experimental Therapeutics. – 2002. – Т. 301. – №. 3. – С. 1067-1078.

12. Verleye M. et al. The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain //Pharmacology Biochemistry and Behavior. – 2005. – Т. 82. – №. 4. – С. 712-720.

13. Serra M. et al. 2‐Phenyl‐imidazo [1, 2‐a] pyridine derivatives as ligands for peripheral benzodiazepine receptors: stimulation of neurosteroid synthesis and anticonflict action in rats //British journal of pharmacology. – 1999. – Т. 127. – №. 1. – С. 177-187.

14. Zhang L. M. et al. Antidepressant-like and anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa) //Neuropharmacology. – 2014. – Т. 81. – С. 116-125.

15. Bitran D. et al. Without Title //Psychopharmacology. – 2000. – Т. 151. – №. 1. – С. 64-71.

16. Primofiore G. et al. N, N-dialkyl-2-phenylindol-3-ylglyoxylamides. A new class of potent and selective ligands at the peripheral benzodiazepine receptor //Journal of medicinal chemistry. – 2004. – Т. 47. – №. 7. – С. 1852-1855.

17. Trapani G. et al. Novel 2-phenylimidazo [1, 2-a] pyridine derivatives as potent and selective ligands for peripheral benzodiazepine receptors: synthesis, binding affinity, and in vivo studies //Journal of medicinal chemistry. – 1999. – Т. 42. – №. 19. – С. 3934-3941.

18. Banister S. D. et al. Ether analogues of DPA-714 with subnanomolar affinity for the translocator protein (TSPO) //European journal of medicinal chemistry. – 2015. – Т. 93. – С. 392-400.

19. Da Settimo F. et al. Anxiolytic-like effects of N, N-dialkyl-2-phenylindol-3-ylglyoxylamides by modulation of translocator protein promoting neurosteroid biosynthesis //Journal of medicinal chemistry. – 2008. – Т. 51. – №. 18. – С. 5798-5806.

20. Mitsui K. et al. Anti-stress effects of ONO-2952, a novel translocator protein 18 kDa antagonist, in rats //Neuropharmacology. – 2015. – Т. 99. – С. 51-66.

21. Kita A. et al. Antianxiety and antidepressant‐like effects of AC‐5216, a novel mitochondrial benzodiazepine receptor ligand //British journal of pharmacology. – 2004. – Т. 142. – №. 7. – С. 1059-1072.

22. Qiu Z. K. et al. Translocator protein mediates the anxiolytic and antidepressant effects of midazolam //Pharmacology Biochemistry and Behavior. – 2015. – Т. 139. – С. 77-83.

23. Okuyama S. et al. Neuropharmacological profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106 //Life sciences. – 1999. – Т. 64. – №. 16. – С. 1455-1464.

24. Mokrov G. V. et al. Design, synthesis and anxiolytic-like activity of 1-arylpyrrolo [1, 2-a] pyrazine-3-carboxamides //Bioorganic & medicinal chemistry. – 2015. – Т. 23. – №. 13. – С. 3368-3378.

25. Патент РФ №2572076 Середенин С.Б., Мокров Г.В., Гудашева Т.А., Деева О.А., Ярков С.А., Яркова М.А., Жердев В.П., Алексеев К.В., Дурнев А.Д., Незнамов Г.Г. 1-арилпирроло[1,2-a]пиразин-3-карбоксамиды с нейропсихотропной активностью

26. Gavioli E. C. et al. Antidepressant-like effect of Ro5-4864, a peripheral-type benzodiazepine receptor ligand, in forced swimming test //European journal of pharmacology. – 2003. – Т. 471. – №. 1. – С. 21-26.

27. Mills C. et al. Ro5‐4864 promotes neonatal motor neuron survival and nerve regeneration in adult rats //European Journal of Neuroscience. – 2008. – Т. 27. – №. 4. – С. 937-946.

28. Ryu J. K., Choi H. B., McLarnon J. G. Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum //Neurobiology of disease. – 2005. – Т. 20. – №. 2. – С. 550-561.

29. Fukaya T. et al. Design, synthesis and structure–activity relationships of novel benzoxazolone derivatives as 18kDa translocator protein (TSPO) ligands //Bioorganic & medicinal chemistry. – 2012. – Т. 20. – №. 18. – С. 5568-5582.

30. Wang D. et al. Anxiolytic-like effects of translocator protein (TSPO) ligand ZBD-2 in an animal model of chronic pain //Molecular pain. – 2015. – Т. 11. – №. 1. – С. 16.

31. Cappelli A. et al. Synthesis and structure–activity relationship studies in translocator protein ligands based on a pyrazolo [3, 4-b] quinoline scaffold //Journal of medicinal chemistry. – 2011. – Т. 54. – №. 20. – С. 7165-7175.

32. Fukaya T. et al. Identification of a novel benzoxazolone derivative as a selective, orally active 18 kDa translocator protein (TSPO) ligand //Journal of medicinal chemistry. – 2013. – Т. 56. – №. 20. – С. 8191-8195.

33. Mínguez J. M. et al. Pyrrolodiazines. 2. Structure and Chemistry of Pyrrolo [1, 2-a] pyrazine and 1, 3-Dipolar Cycloaddition of Its Azomethine Ylides //The Journal of organic chemistry. – 1996. – Т. 61. – №. 14. – С. 4655-4665.

34. В. И. Шведов, Л. Б. Алтухова, А. Н. Гринев, «Новый метод синтеза пирроло[1,2-а]пиразинов и пирроло[1,2-а]хиноксалинов» // Химия гетероцикл. соединений, 1970, – С 1048-1050.

35. Chen W. et al. Domino Approach for the Synthesis of Pyrrolo [1, 2-α] pyrazine from Vinyl Azides //Organic letters. – 2010. – Т. 12. – №. 17. – С. 3863-3865.

36. Alfonsi M. et al. Microwave‐Promoted Synthesis of N‐Heterocycles by Tandem Imination/Annulation of γ‐and δ‐Ketoalkynes in the Presence of Ammonia //European Journal of Organic Chemistry. – 2009. – Т. 2009. – №. 17. – С. 2852-2862.

37. Glaxo Group Limited, "Compounds", WO Patent 2007/088168 (2007), Glaxo Group Limited, "Combination of CB2 ligand and paracetamol", WO Patent 2008/116816 (2008).

38. Bristol-Myers Squibb Company, «Hepatitis C Virus Inhibitors», US Patent 0195857 (2012).

39. Донцова Н. Е., Шестопалов А. М., Литвинов В. П. СИНТЕЗ ЗАМЕЩЕННЫХ 7, 8-ДИ (ПРОПИЛСУЛЬФОНИЛ) ПИРРОЛО [1, 2-А] ПИРАЗИНОВ //Известия. – 2008. – №. 2. – С. 424-426.

40. Muzalevskiy V. M. et al. α-Trifluoromethyl-β-aryl enamines in the synthesis of trifluoromethylated heterocycles by the Fischer and the Pictet–Spengler reactions //Tetrahedron. – 2009. – Т. 65. – №. 36. – С. 7553-7561.

41. Katritzky A. R., He H. Y., Jiang R. Convenient syntheses of dihydropyrrolo [2′, 1′: 3, 4] pyrazino-and dihydropyrrolo [2′, 1′: 3, 4][1, 4] diazepino-[2, 1-a] isoindolones //Tetrahedron letters. – 2002. – Т. 43. – №. 15. – С. 2831-2833.

42. Arban R. et al. Pyrrolo [1, 2-a] pyrazine and pyrazolo [1, 5-a] pyrazine: novel, potent, and selective series of Vasopressin 1b receptor antagonists //Bioorganic & medicinal chemistry letters. – 2010. – Т. 20. – №. 17. – С. 5044-5049.

43. Reisser M., Maas G. Synthesis of Pyrroles from 1-Dialkylamino-3-phosphoryl (or phosphanyl) allenes through 1, 5-Cyclization of Conjugated Azomethine Ylide Intermediates //The Journal of organic chemistry. – 2004. – Т. 69. – №. 15. – С. 4913-4924.

44. Teijin Limited, "Pyrrolopyrimidine derivative", EP Patent 1477490 (2004)

45. Herz W., Tocker S. The Pomeranz-Fritsch Reaction in the Pyrrole Series. The Synthesis of Apoharmine1 //Journal of the American Chemical Society. – 1955. – Т. 77. – №. 23. – С. 6355-6357.

46. В. П. Пересада, О. С. Медведев, А. М. Лихошерстов, А. П. Сколдинов. Азациклоалканы. XXX. Пирроло[1,2-а]пиразины с различной степенью насыщенности пиразинового цикла и их гипотензивная активность//Хим.-фарм. журн. – 1987. – №21. – С. 1054-1059.

47. Micheli F. et al. Phenylethynyl-pyrrolo [1, 2-a] pyrazine: A new potent and selective tool in the mGluR5 antagonists arena //Bioorganic & medicinal chemistry letters. – 2008. – Т. 18. – №. 6. – С. 1804-1809.

48. Shionogi and Co., Ltd., "Pyrrolo[1,2-a]pyrazine SPLA2 inhibitor", US Patent 6407104 (2002), (b) Shionogi and Co., Ltd., "Tricyclic azaindolizine derivatives having an SPLA2-inhibitory activities", US Patent 6756376 (2004).

49. В. И. Теренин, М. В. Галкин, Е. В. Кабанова, А. С. Иванов, "1-(Трифторметил)-3,4-дигидропирроло[1,2-a]пиразины: синтез и превращения под действием O- и N-нуклеофилов", Химия гетероцикл. Соединений//2010. - С 1569-1578

50. Free S. M., Wilson J. W. A mathematical contribution to structure-activity studies //Journal of Medicinal Chemistry. – 1964. – Т. 7. – №. 4. – С. 395-399.

51. Mitra I., Saha A., Roy K. Predictive modeling of antioxidant coumarin derivatives using multiple approaches: descriptor-based QSAR, 3D-pharmacophore mapping, and HQSAR //Scientia pharmaceutica. – 2012. – Т. 81. – №. 1. – С. 57-80

52. Gramatica P. Principles of QSAR models validation: internal and external //Molecular Informatics. – 2007. – Т. 26. – №. 5. – С. 694-701.

53. Irwin J. J. et al. ZINC: a free tool to discover chemistry for biology //Journal of chemical information and modeling. – 2012. – Т. 52. – №. 7. – С. 1757-1768.

54. Sushko I. et al. Online chemical modeling environment (OCHEM): web platform for data storage, model development and publishing of chemical information //Journal of computer-aided molecular design. – 2011. – Т. 25. – №. 6. – С. 533-554.

55. Varnek A. et al. ISIDA-Platform for virtual screening based on fragment and pharmacophoric descriptors //Current Computer-Aided Drug Design. – 2008. – Т. 4. – №. 3. – С. 191-198

56. Morris G. M. et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility //Journal of computational chemistry. – 2009. – Т. 30. – №. 16. – С. 2785-2791.

57. Jaremko Ł. et al. Structure of the mitochondrial translocator protein in complex with a diagnostic ligand //Science. – 2014. – Т. 343. – №. 6177. – С. 1363-1366.

58. Gasteiger J., Marsili M. Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges //Tetrahedron. – 1980. – Т. 36. – №. 22. – С. 3219-3228.

59. Lipinski C. A. Lead-and drug-like compounds: the rule-of-five revolution //Drug Discovery Today: Technologies. – 2004. – Т. 1. – №. 4. – С. 337-341.

60. Hansch C., Leo A. Substituent constants for correlation analysis in chemistry and biology. – Wiley, 1979.

61. ГОСТ Р 50258-92 [1993].

62. Barbe G., Charette A. B. Highly chemoselective metal-free reduction of tertiary amides //Journal of the American Chemical Society. – 2008. – Т. 130. – №. 1. – С. 18-19.

63. Milen M. et al. Synthesis of a new compound family, 1-aryl-3H-pyrrolo [2, 1-d][1, 2, 5] triazepin-4 (5H)-ones //Tetrahedron. – 2014. – Т. 70. – №. 2. – С. 465-476.

64. Shibanuma T. et al. Thermosensitive Phase-Separation Behavior of Poly(acrylic acid)-graft-poly(N,N-dimethylacrylamide) Aqueous Solution // Macromolecules. – 2000. – №33. – C. 444-450.

65. Gilchrist T. L., Mendonça R. Synthesis and Diels–Alder reactions of 2H-azirine-3-carboxamides //Arkivoc. – 2000. – Т. 769. – С. 778.

66. Kakimoto M., Kai M., Kondo K. A simple synthesis of 2-azides-2-alkenoates //Chemistry Letters. – 1982. – Т. 11. – №. 4. – С. 525-526.